Soc. Generale Discount Zert GS7 2.../ DE000SF4VRX6 /
5/20/2022 6:48:53 PM | Chg.0.00 | Bid10:00:25 PM | Ask10:00:25 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
11.93EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
GSK PLC L... | - - | 9/23/2022 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...